Depression Treatment Planning for Family Medicine Bo... | MDster You are offline Back online! [ ](/) Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Depression Treatment Planning in Family Medicine: Aim for Remission [ Medical Education ](https://mdster.com/blog?category=medical-education) Depression Treatment Planning in Family Medicine: Aim for Remission ===================================================================== A practical, board-focused approach to measurement-based care, psychotherapy referral, SSRI/SNRI prescribing, follow-up timing, and relapse prevention. [ MDster Editorial Team ](https://mdster.com/about) · Apr 13, 2026 · 7 min read · 32 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Family Medicine ](https://mdster.com/blog?tag=family-medicine) [ Perinatal Mental Health ](https://mdster.com/blog?tag=perinatal-mental-health) [ Depression ](https://mdster.com/blog?tag=depression) [ Behavioral Health ](https://mdster.com/blog?tag=behavioral-health) [ Geriatric Care ](https://mdster.com/blog?tag=geriatric-care) ![Depression Treatment Planning in Family Medicine: Aim for Remission](https://mdster.com/storage/blog/images/depression-treatment-planning-in-family-medicine-aim-for-remission.jpg) Share this article Share this post Most residents do not fail depression care because they forget sertraline. They fail because they never define the target, never remeasure, and never build follow-up into the plan. In family medicine, that leaves patients stuck as partial responders, and that is exactly where relapse, perinatal undertreatment, and late-life adverse effects become common. Treat depression the way you treat hypertension: set a goal, check the number, and change the plan when the number refuses to move. [\[1\]](#cite-1 "Reference [1]") Start With a Remission Target ----------------------------- Measurement-based care is not an academic extra; it is how you keep vague follow-up from turning into undertreatment. Use a baseline **PHQ-9**, repeat it at follow-up, and let the score guide the next step. The VA/DoD guideline defines **response** as at least a 50% improvement from baseline and **remission** as a PHQ score of 4 or less maintained for at least 1 month. Boards love this distinction, and patients feel it: a PHQ-9 drop from 18 to 10 is better, but it is not well. [\[1\]](#cite-1 "Reference [1]") Use these targets in clinic and on exams. [\[1\]](#cite-1 "Reference [1]") OutcomePractical PHQ targetWhat it meansResponse≥50% improvement from baselineKeep going, but do not declare victoryRemissionPHQ-9 ≤4 for at least 1 monthThis is the treatment goalRecoveryPHQ-9 ≤4 for at least 6 monthsNow you are in relapse-prevention territory If there is no meaningful movement, do not drift. Recheck adherence, bipolar history, substance use, grief, medical mimics, and whether the treatment was ever truly therapeutic. NICE recommends reviewing how treatment is working between 2 and 4 weeks after starting treatment, and if there is no response after 4 weeks of a therapeutic antidepressant dose, revisit the plan rather than waiting passively. [\[2\]](#cite-2 "Reference [2]") Choose the First-Line Lane -------------------------- For initial treatment, shared decision-making matters, but be concrete. If the patient wants psychotherapy, refer for an actual modality, not a vague request for counseling. VA/DoD lists **CBT, interpersonal therapy, behavioral activation, mindfulness-based cognitive therapy, problem-solving therapy, ACT,** and **short-term psychodynamic psychotherapy** as evidence-based options. In primary care, CBT, IPT, BA, and PST are the most practical names to use on the referral. [\[1\]](#cite-1 "Reference [1]") If you choose medication, **SSRIs and SNRIs** remain core first-line options. Discuss the choice around prior response, adverse effects the patient most wants to avoid, comorbidities, interactions, overdose risk, and patient preference. Tell patients up front that benefit, if it is going to occur, is usually evident within about 4 weeks, and warn them not to stop abruptly because withdrawal can occur across antidepressant classes; **paroxetine** and **venlafaxine** are especially withdrawal-prone. [\[1\]](#cite-1 "Reference [1]") Follow-Up Is Part of the Prescription ------------------------------------- Do not prescribe an antidepressant without prescribing the next contact. NICE recommends a first review usually within 2 weeks to assess improvement and side effects, with earlier review at 1 week for patients aged 18 to 25 years or anyone with suicide-risk concerns; after that, ongoing review should be individualized, but not later than 4 weeks from initiation in those higher-risk groups. [\[2\]](#cite-2 "Reference [2]") > **Clinical Pearl:** Before the patient leaves, put the PHQ-9, the follow-up date, and the threshold for changing course into the after-visit summary. If you do not operationalize follow-up, you have not really made a treatment plan. A practical primary care rule is simple: if PHQ-9 is improving and side effects are tolerable, continue and titrate thoughtfully toward remission; if there is no response, troubleshoot and change something. For severe depression or partial response, VA/DoD supports combining pharmacotherapy with evidence-based psychotherapy rather than endlessly shuffling half-measures. [\[2\]](#cite-2 "Reference [2]") Perinatal and Late-Life Nuance ------------------------------ Perinatal depression punishes therapeutic timidity. ACOG advises against withholding or discontinuing indicated psychiatric medication solely because a patient is pregnant or lactating, and it emphasizes dose titration with the goal of remission. In practice, that means weighing prior response and current severity, involving OB colleagues early, and using validated tools such as the **PHQ-9** or **EPDS** repeatedly; ACOG implementation resources recommend readministering screening tools monthly and as needed to track effectiveness and push toward full symptom remission. [\[3\]](#cite-3 "Reference [3]") Late-life depression punishes sloppy prescribing. In older adults, account for comorbid illness, drug interactions, falls, fractures, and **hyponatremia** risk, especially with concurrent diuretics. Monitor side effects closely, but do not confuse caution with undertreatment: the goal is still remission, not leaving a 78-year-old on a forever-starter dose that never had a chance to work. [\[2\]](#cite-2 "Reference [2]") Relapse Prevention Is Active Treatment -------------------------------------- Response is not the finish line. VA/DoD recommends continuing the effective antidepressant at the therapeutic dose for at least 6 months after remission, and for patients with recurrent episodes or other high-risk features, treatment often needs to continue at least 12 months and sometimes indefinitely. The same guideline suggests **CBT, IPT,** or **MBCT** during the continuation phase for patients at high risk of relapse or recurrence. [\[1\]](#cite-1 "Reference [1]") This is a classic board trap: stopping medication once the patient feels 50% better. That is response, not remission, and discontinuation after response carries substantial relapse risk. Also remember that early discontinuation symptoms are not the same as relapse; withdrawal is especially common with paroxetine and venlafaxine and can begin within days of dose reduction. [\[1\]](#cite-1 "Reference [1]") Key Takeaways ------------- - **Treat to remission, not just response.** Use serial PHQ-9 scores and write the target down. [\[1\]](#cite-1 "Reference [1]") - **Refer specifically for psychotherapy.** Ask for CBT, IPT, BA, or PST, not generic counseling. [\[1\]](#cite-1 "Reference [1]") - **Build follow-up into the initial plan.** Review most patients within 2 weeks; use 1 week if age 18 to 25 or suicide risk is a concern. [\[2\]](#cite-2 "Reference [2]") - **In perinatal care, do not stop effective medication just because of pregnancy or lactation.** Monitor with validated tools and titrate toward remission. [\[3\]](#cite-3 "Reference [3]") - **In late-life care, watch for falls, hyponatremia, and polypharmacy—but do not undertreat.** [\[2\]](#cite-2 "Reference [2]") - **After remission, continue treatment long enough to prevent relapse.** At least 6 months is standard after a first episode; longer is often needed for recurrent depression. [\[1\]](#cite-1 "Reference [1]") Conclusion ---------- Good depression treatment planning in family medicine is disciplined, not fancy. Measure symptoms, name the treatment target, match the first-line option to the patient in front of you, and schedule follow-up before you congratulate yourself for starting therapy. If you aim only for partial improvement, partial improvement is what you will keep getting. [\[1\]](#cite-1 "Reference [1]") Frequently Asked Questions ---------------------------- Is a 50% PHQ-9 reduction enough to stop escalating treatment? No. That is **response**, not **remission**. The treatment target is remission, defined in the VA/DoD guideline as a PHQ score of 4 or less maintained for at least 1 month. [\[1\]](#cite-1 "Reference [1]") Which psychotherapy names should I actually use in a referral? Use evidence-based modalities by name: **CBT, IPT, behavioral activation,** or **problem-solving therapy** are strong primary care choices. [\[1\]](#cite-1 "Reference [1]") When should I follow up after starting an SSRI or SNRI? Usually within **2 weeks**. Follow up at **1 week** if the patient is age 18 to 25 years or there is concern about suicide risk. [\[2\]](#cite-2 "Reference [2]") How long should antidepressants be continued after remission? At least **6 months** after remission for a first episode, and often **12 months or longer** for recurrent or high-risk depression. [\[1\]](#cite-1 "Reference [1]") Should pregnancy or breastfeeding automatically trigger antidepressant discontinuation? No. ACOG recommends against withholding or discontinuing indicated psychiatric medication solely because of pregnancy or lactation status. [\[3\]](#cite-3 "Reference [3]") References (5) ------------------ 1. 1. [ VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022) ](https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/MH/mdd/VADODMDDCPGFinal508.pdf) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ NICE Guideline NG222: Depression in adults: treatment and management ](https://www.nice.org.uk/guidance/ng222/chapter/recommendations) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ www.acog.org/programs/perinatal-mental-health/assessment-and-treatment-of-perinatal-mental-health-conditions ](https://www.acog.org/programs/perinatal-mental-health/assessment-and-treatment-of-perinatal-mental-health-conditions) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ ACOG Clinical Practice Guideline No. 5: Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum ](https://www.acog.org/clinical/clinical-guidance/clinical-practice-guideline/articles/2023/06/treatment-and-management-of-mental-health-conditions-during-pregnancy-and-postpartum) 5. 5. [ ACOG: Implementing Perinatal Mental Health Screening ](https://www.acog.org/programs/perinatal-mental-health/implementing-perinatal-mental-health-screening) Keep going Stay consistent in Family Medicine prep with a guided pathway --------------------------------------------------------------- - Broad coverage without the overwhelm - Short daily sessions that compound - See your progress and focus on weak areas [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Family Medicine ](https://mdster.com/speciality/family-medicine) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features. No commitment. Cancel anytime. Explore topics: [ # Family Medicine ](https://mdster.com/blog?tag=family-medicine) [ # Perinatal Mental Health ](https://mdster.com/blog?tag=perinatal-mental-health) [ # Depression ](https://mdster.com/blog?tag=depression) [ # Behavioral Health ](https://mdster.com/blog?tag=behavioral-health) [ # Geriatric Care ](https://mdster.com/blog?tag=geriatric-care) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Medical Education ------------------------- [ See all ](https://mdster.com/blog?category=medical-education) [### Malignant Pleural Effusion: Diagnosis, Prognosis, and Management 7 min read Apr 12, 2026 ](https://mdster.com/blog/malignant-pleural-effusion-diagnosis-prognosis-and-management) [### Pediatric Hemangiomas and Vascular Lesions: A Practical Overview 6 min read Apr 11, 2026 ](https://mdster.com/blog/pediatric-hemangiomas-and-vascular-lesions-a-practical-overview) [### Coagulopathy-Directed Therapy in Massive Hemorrhage 4 min read Apr 10, 2026 ](https://mdster.com/blog/coagulopathy-directed-therapy-in-massive-hemorrhage) Related Posts ------------- [ ![Malignant Pleural Effusion: Diagnosis, Prognosis, and Management](https://mdster.com/storage/blog/images/malignant-pleural-effusion-diagnosis-prognosis-and-management.jpg) Medical Education ### Malignant Pleural Effusion: Diagnosis, Prognosis, and Management Malignant pleural effusion is more than recurrent dyspnea. Learn how to interpret cytology yield, choose IPC versus pleurodesis, and use prognosis to guide bedside care. 7 min read 0 comments ](https://mdster.com/blog/malignant-pleural-effusion-diagnosis-prognosis-and-management) [ ![Pediatric Hemangiomas and Vascular Lesions: A Practical Overview](https://mdster.com/storage/blog/images/pediatric-hemangiomas-and-vascular-lesions-a-practical-overview.jpg) Medical Education ### Pediatric Hemangiomas and Vascular Lesions: A Practical Overview A focused pediatric guide to infantile hemangiomas and vascular lesions, with high-yield clues for distinguishing malformations and knowing when propranolol should not wait. 6 min read 0 comments ](https://mdster.com/blog/pediatric-hemangiomas-and-vascular-lesions-a-practical-overview) [ ![Coagulopathy-Directed Therapy in Massive Hemorrhage](https://mdster.com/storage/blog/images/coagulopathy-directed-therapy-in-massive-hemorrhage.jpg) Medical Education ### Coagulopathy-Directed Therapy in Massive Hemorrhage A high-yield anesthesiology review of coagulopathy-directed therapy in massive hemorrhage, with a practical focus on fibrinogen, platelets, and viscoelastic testing. 4 min read 0 comments ](https://mdster.com/blog/coagulopathy-directed-therapy-in-massive-hemorrhage) [ ![Abdominal Pain in Older Adults: Mesenteric Ischemia, AAA, Volvulus](https://mdster.com/storage/blog/images/abdominal-pain-in-older-adults-mesenteric-ischemia-aaa-volvulus.jpg) Case Discussion ### Abdominal Pain in Older Adults: Mesenteric Ischemia, AAA, Volvulus A board-style case discussion on diffuse abdominal pain in an older adult with atrial fibrillation, emphasizing mesenteric ischemia, AAA, sigmoid volvulus, CTA, and parallel resuscitation. 6 min read 0 comments ](https://mdster.com/blog/abdominal-pain-in-older-adults-mesenteric-ischemia-aaa-volvulus) [ ![Compartment Syndrome and Crush Injury Disposition in the ED](https://mdster.com/storage/blog/images/compartment-syndrome-and-crush-injury-disposition-in-the-ed.jpg) Medical Education ### Compartment Syndrome and Crush Injury Disposition in the ED Disposition is treatment in compartment syndrome and crush injury. Learn who needs the OR, monitored admission, serial electrolyte checks, or urgent transfer. 6 min read 0 comments ](https://mdster.com/blog/compartment-syndrome-and-crush-injury-disposition-in-the-ed) [ ![Medication Considerations in PTSD: SSRIs, SNRIs, Prazosin](https://mdster.com/storage/blog/images/medication-considerations-in-ptsd-ssris-snris-prazosin.jpg) Medical Education ### Medication Considerations in PTSD: SSRIs, SNRIs, Prazosin A board-focused review of PTSD pharmacotherapy: when to choose sertraline, paroxetine, or venlafaxine, why benzodiazepines are a trap, and how to use prazosin carefully for nightmares. 7 min read 0 comments ](https://mdster.com/blog/medication-considerations-in-ptsd-ssris-snris-prazosin) [ ](/) Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) ### Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) ### Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) ### Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept